Company Filing History:
Years Active: 2011-2014
Title: Kevin J Wells-Knecht: Innovator in Histamine H Antagonist Compounds
Introduction
Kevin J Wells-Knecht is a notable inventor based in Glenmoore, PA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with histamine H antagonist activity. With a total of 2 patents to his name, his work has implications for various therapeutic applications.
Latest Patents
Wells-Knecht's latest patents focus on substituted pyridazine derivatives. The present invention is directed to compounds having histamine H antagonist activity, as well as methods of their use and preparation. This innovative approach has the potential to enhance treatment options for conditions related to histamine activity.
Career Highlights
Kevin J Wells-Knecht is associated with Cephalon, Inc., a company known for its commitment to developing innovative therapies. His work at Cephalon has allowed him to explore and expand the possibilities within the pharmaceutical industry.
Collaborations
Throughout his career, Wells-Knecht has collaborated with esteemed colleagues, including Robert L Hudkins and Lars J S Knutsen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kevin J Wells-Knecht stands out as an inventor dedicated to advancing the field of medicinal chemistry through his innovative patents. His contributions to the development of histamine H antagonist compounds reflect his commitment to improving therapeutic options.